Abstract—
In most cases, breast cancer is a malignant neoplasm associated with infiltration of a tumor with the cells that form its microenvironment and produce various cytokines. The aim of the study was to evaluate the cytokine-producing function of tumor cells and their microenvironment in biopsy samples of patients with invasive breast carcinoma of no special type (IBC-NST; group I) and in patients with benign breast diseases (BBD, group II). Patients of group II were further divided into group IIa, which included patients only with fibroadenoma, and group IIb, which included patients with leaf-shaped fibroadenoma, fibroadenomatosis, fibrocystic mastopathy, intraductal papillomatosis and sclerosing adenosis and fibrocystic mastopathy microcalcifications. Concentrations of IL-2, IL-6, IL-8, IL-10, IL-17, IL-18, IL-1β, IL-1Ra, TNF-α, IFN-γ, G-CSF, GM-CSF, VEGF, and MCP-1 were measured in supernatants of breast biopsy samples. The cytokine-producing activity of tumor biopsy samples and its microenvironment was assessed by the index of the polyclonal activator influence (IPAI) on cytokine production. Comparison of groups I and II, revealed high IPAI values on production of IL-17, IL-18 and TNF-α in BBD patients (group II). Higher IPAI values on production of IL-18, TNF-α, and IL-1β and the ratio of IL1β/IL1Ra were observed in BDD patients with fibroadenoma as compared to IBC-NST patients. No statistically significant differences in the IPAI values were found between groups I and IIb. This suggests the existence of changes in the mammary gland in patients of group IIb similar to those in breast carcinoma (IBC-NST) patients. Comparison of groups IIa and IIb revealed higher IPAI values in group IIa (fibroadenoma) patients on production of IL-1β, as well as the ratio of IL1β/IL1Ra. The results of this study have shown some features of the cytokine-producing resource of breast biopsy samples from patents with IBC-NST and BDD.
Similar content being viewed by others
REFERENCES
Fabre, J., Giustiniani, J., Garbar, C., Antonicelli, F., Merrouche, Y., Bensussan, A., Bagot, M., and Al-Dacak, R., Int. J. Mol. Sci., 2016, vol. 17, no. 9, 1433. https://doi.org/10.3390/ijms17091433
Joyce, J.A., and Fearon, D.T., Science, 2915, vol. 348, pp. 74−80. https://doi.org/10.1126/science.aaa6204
Quail, D.F., Bowman, R.L., Akkari, L., Quick, M.L., Schuhmacher, A.J., Huse, J.T., Holland, E.C., Sutton, J.C., and Joyce, J.A., Science, 2016, vol. 352, p. 6288. https://doi.org/10.1126/science.aad3018
Soria, G., Ofri-Shahak, M., Haas, I., Yaal-Hahoshen, N., Leider-Trejo, L., Leibovich-Rivkin, T., Weitzenfeld, P., Meshel, T., Shabtai, E., Gutman, M., and Ben-Baruch, A., BMC Cancer, 2011, vol. 11, 130. https://doi.org/10.1186/1471-2407-11-130
Bowman, R.L. and Joyce, J.A., Immunotherapy, 2014, vol. 6, pp. 663−666. https://doi.org/10.2217/imt.14.48
Castells, X., Domingo, L., Corominas, J.M., Torá-Rocamora, I., Quintana, M.J., Baré, M., Vidal, C., Natal, C., Sánchez, M., Saladié, F., Ferrer, J., Vernet, M., Servitja, S., Rodríguez-Arana, A., Roman, M., Espinàs, J.A., and Sala, M., Breast Cancer Res. Treat., 2015, vol. 1, no. 149, pp. 237−244. https://doi.org/10.1007/s10549-014-3208-z
Posso, M., Corominas, J.M., Serrano, L., Roman, M., Torá-Rocamora, I., Domingo, L., Romero, A., Quintana, M.J., Vernet-Tomas, M., Baré, M., Vidal, C., Sánchez, M., Saladié, F., Natal, C., Ferrer, J., Servitja, S., Sala, M., and Castells, X., Cancer Med., 2017, vol. 6, pp. 1482−1509. https://doi.org/10.1002/cam4.1080
Salamat, F., Niakan, B., Keshtkar, A., Rafiei, E., and Zendehdel, M., Iran. J. Med. Sci., 2018, vol. 43, no. 4, pp. 355−364. https://doi.org/10.1002/cam4.1080
Zendehdel, M., Niakan, B., Keshtkar, A., Rafiei, E., and Salamat, F., Iran. J. Med. Sci., 2018, vol. 43, no. 1, pp. 1−8. PMCID: PMC5775989.
World Medical Association, JAMA, 2013, vol. 310, pp. 2191–2194.
Autenshlyus, A., Arkhipov, S., Mikhailova, E., Marinkin, I., Arkhipova, V., Mogilnaya, E., Varaksin, N., and Rukavishnikov, M., Int. J. Immunopathol. Pharmacol., 2017, vol. 30, no. 3, pp. 308−314. https://doi.org/10.1177/0394632017720055
Freeman, A.E. and Hoffman, R.M., Proc. Natl. Acad. Sci. USA, 1986, vol. 83, no. 8, pp. 2694−2698. https://doi.org/10.1073/pnas.83.8.2694
Yang, B., Kang, H., Fung, A., Zhao, H., Wang, T., and Ma, D., Mediators Inflamm., 2014, vol. 2014, 623759. https://doi.org/10.1155/2014/623759
Lyon, D.E., McCain, N.L., Walter, J., and Schubert, C., Nurs. Res., 2008, vol. 57, pp. 51−58. https://doi.org/10.1097/01.NNR.0000280655.58266.6c
Park, I.H., Yang, H.N., Lee, K.J., Kim, T.S., Lee, E.S., Jung, S.Y., Kwon, Y., and Kong, S.Y., Oncotarget., 2017, vol. 8, no. 20, pp. 32722−32730. https://doi.org/10.18632/oncotarget.16281
Yasuda, K., Nakanishi, K., and Tsutsui, H., Int. J. Mol. Sci., 2019, vol. 20, no. 3, 649. https://doi.org/10.3390/ijms20030649
Katanov, C., Lerrer, S., Liubomirski, Y., Leider-Trejo, L., Meshel, T., Bar, J., Feniger-Barish, R., Kamer, I., Soria-Artzi, G., Kahani, H., Banerjee, D., and Ben-Baruch, A., Stem. Cell. Res. Ther., 2015, vol. 6, no. 1, 87. https://doi.org/10.1186/s13287-015-0080-7
Tulotta, C. and Ottewell, P., Endocrine-Related Cancer, 2018, vol. 25, no. 7, pp. 421−434. https://doi.org/10.1530/ERC-17-0309
Nutter, F., Holen, I., Brown, H.K., Cross, S.S., Evans, C.A., Walker, M., Coleman, R.E., West-brook, J.A., Selby, P.J., Brown, J.E., and Otte-well, P.D., Endocrine-Related Cancer, 2014, vol. 21, pp. 327−341. https://doi.org/10.1530/ERC-13-0158
Degnim, A.C., Nassar, A., Stallings-Mann, M., Keith Anderson, S., Oberg, A.L., Vierkant, R.A., Frank, R.D., Wang, C., Winham, S.J., Frost, M.H., Hartmann, L.C., Visscher, D.W., and Radisky, D.C., Breast Cancer Res. Treat., 2015, vol. 3, no. 152, pp. 687−694. https://doi.org/10.1007/s10549-015-3513-1
Visscher, D.W., Nassar, A., Degnim, A.C., Frost, M.H., Vierkant, R.A., Frank, R.D., Tarabishy, Y., Radisky, D.C., and Hartmann, L.C., Breast Cancer Res. Treat., 2014, vol. 1, no. 144, pp. 205−212. https://doi.org/10.1007/s10549-014-2862-5
Al-Zhoughbi, W., Huang, J., and Paramasivan, G.S., Semin. Oncol., 2014, vol. 41, no. 2, pp. 281−295. https://doi.org/10.1053/j.seminoncol.2014.02.005
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All studies were performed in accordance with the Helsinki Declaration [10]. Each patient was informed about the research, its purpose and methods and each patient gave informed consent to conduct this study and obtain samples of tumor biopsy samples; such consent was signed by the patient and certified by a doctor. The Ethics Committee of the Research Institute of Molecular Biology and Biophysics, a division of the Federal Research Center for Fundamental and Translational Medicine (Novosibirsk), gave permission for this study.
The authors declare that they have no conflict of interest.
Additional information
Translated by A. Medvedev
Rights and permissions
About this article
Cite this article
Autenshlyus, A.I., Studenikina, A.A., Bernado, A.V. et al. Assessment of the Cytokine-Producing Resource of Tumor Biopsy Samples from Patients with Invasive Carcinoma of No Special Type and with Non-Malignant Breast Diseases. Biochem. Moscow Suppl. Ser. B 14, 38–43 (2020). https://doi.org/10.1134/S1990750820010047
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750820010047